This is in reply to the query received from BSE dated 18th August 2025 pertaining to resignation of Mr. Manoj Lodha as Chief Financial Officer of the Company w.e.f. 5th August 2025. Resignation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts more than Nifty Microcap 250 and 2.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sudarshan Pharma Industries Ltd has submitted the resignation letter of its Chief Financial Officer, Mr. Manoj Lodha, to BSE after the exchange sought additional details on a delayed disclosure. Mr. Lodha stepped down from the CFO role effective 5th August 2025, citing a higher strategic role in a different industry/sector as the reason. The company confirmed Mr. Lodha is not related to any of its directors. BSE had originally flagged that the resignation letter was not submitted within the required 7-day window under SEBI LODR regulations.
Investors should note the departure of a key financial executive, which may create short-term uncertainty around financial reporting continuity. However, the resignation is for personal career reasons rather than governance red flags, and the company has now complied with disclosure requirements.